Cigna CI Earnings Analysis

Earnings Analysis for CI for 2023 to 2024

Revenue Analysis:

Total and Operating Revenue: CI showed a fluctuating trend in Total and Operating Revenue across the studied periods. From the first quarter of 2023 ($46.461 billion), there was steady growth, peaking in the final quarter of 2024 to approximately $55.419 billion. A year-over-year increase, this growth may indicate an expanding market presence or improved sales strategies.

Gross Profit Margin: Given the data, we calculate CI’s gross profit margin by subtracting the operating expenses from the revenues. However, Gross Profit itself is not explicitly mentioned.

Cost Management:

Operating Expense and Total Expenses: CI managed its operating expenses at a steady pace; starting from approximately $31.459 billion in Q1 2023 and increasing to over $41.431 billion by Q1 2024. Total expenses increased from $44.86 billion in Q1 2023 to $55.34 billion by the end of Q1 2024, reflecting significant escalation possibly due to expanding operations or rising costs.

Profitability Analysis:

EBITDA: Not explicitly provided in the raw data but can be estimated by adding Reconciled Depreciation to EBIT.

Operating Income (EBIT) and Pretax Income: EBIT fluctuated, reaching $2.205 billion by the end of Q3 2023 but significantly dropping in Q1 2024 to $401 million before recovering somewhat. Pretax income saw a considerable drop in Q1 2024 to $79 million from higher values in previous quarters.

Net Income: CI experienced volatile Net Income, reaching a low of -$277 million by Q1 2024, contrasting with the profitability observed in prior periods such as $1.458 billion in Q2 2023.

Cash Flow Indicators:

Reconciled Depreciation: Gradual increase observed, starting from $749 million in Q1 2023 to $741 million in Q1 2024. This indicates ongoing asset depreciation, consistent with business expansion and continued investment in asset-heavy sectors.

Interest Expense: There has been a consistent expenditure on interest, reflecting stable but significant financing activities, ranging around $360 million quarterly.

Taxation:

Tax Rate, Tax Provision, and Tax Effect of Unusual Items: The effective tax rate has shown variations from 18.4% to 21%. The adverse financial results in the latest quarter diminished tax provisions to a credit situation, highlighting significant fiscal impacts on CI’s financial strategies.

Shareholder Metrics:

Diluted and Basic EPS: Earnings per share fluctuated drastically, peaking at $4.96 in Q2 2023 and dropping significantly to -$0.97 by Q1 2024, signifying stress in profit generation in the latest period.

Net Income Available to Common Stockholders: Mirroring the net income trend, available income for stockholders showed critical drops, adversely affecting shareholder value in recent times.

Conclusion:

CI’s financial journey over the last three fiscal periods unveils a scenario of initial profit gain turning into recent substantial losses. Key concerns would be the stark decrease in profitability and the high costs/operational expenses which might be absorbing the revenue gains. CI must strategize on improving cost-efficiency and possibly reassess financial and operational strategies to stabilize and improve profitability.

Appendices:

Data tables not included.